fluoroscopy-systems-market

Fluoroscopy Systems Market By Device Type (Fluoroscopy Devices, C-Arms), By Application (Cardiac Procedures, Orthopedic Procedures, Vascular And Neurological Procedures), By Usage Area (Hospitals And Specialty Clinics, Diagnostic Centers) - Growth, Share, Opportunities & Competitive Analysis, 2015 – 2025

16 Aug 2017 Format PDF icon PPT icon XLS icon Request Sample

Significant growth in geriatric population and rise in incidence of chronic diseases worldwide are some of the most prominent drivers of fluoroscopy systems market. Technological advancement in the field of fluoroscopy, rapid development of healthcare infrastructure and growing implementation of image guided surgeries are also driving the global fluoroscopy systems market. This market is also characterized by growing M&A activities, distribution agreements and partnerships undertaken by market players to enhance their geographic footprint. Fluoroscopy and C-arms are widely used medical imaging systems in several diagnostic and surgical procedures. Fluoroscopy is most commonly used in image-guided surgical procedures, and interventional and general radiology. Whereas C-arms are widely used in trauma surgeries, cardiac, orthopedic and vascular surgeries.

The purpose of this research study titled ‘Fluoroscopy Systems Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global fluoroscopy systems market. This report presents and analyzes the major trends prevalent in the global fluoroscopy devices market and the market size and forecast.

This report categorizes the global fluoroscopy devices market in terms of device type, application, usage areas and geographical distribution. Based on device type, the global fluoroscopy systems market is categorized into fluoroscopy devices and C-arms - mini C-arms and full size C-arms. Based on applications, this market is categorized into cardiac procedures, orthopedic procedures, vascular and neurological procedures, and others. Additionally, hospitals and specialty clinics, and diagnostic centers are the major usage areas considered for the purpose of this study. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of device type, applications, usage areas and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global fluoroscopy systems market. Competition assessment tools such as, major agreements, partnerships and collaborations, market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the fluoroscopy systems market. The key players profiled in this report are Allengers Medical Systems, Carestream Health, Fujifilm Holdings, GE Healthcare, Hitachi Medical Systems, Hologic, Inc., Orthoscan, Inc., Philips Healthcare, Siemens Healthineers, Shimadzu Corporation, Toshiba Medical Systems, Varian Medical Systems and Ziehm Imaging.

Based on the type, the global fluoroscopy systems market is segmented as follows:

  • Fluoroscopy Devices
  • C-Arms
    • Mini C-Arms
    • Full Size C-Arms

Between fluoroscopy devices and C-arms, the fluoroscopy devices segment held over 65% of the global revenue share in 2016. The dominance of this segment is attributed to significant range of surgical and diagnostic procedures being performed under fluoroscopic guidance. Growing application of fluoroscopy in previously unexplored areas such as nondestructive testing, quality assurance and other diagnostic procedures will create lucrative opportunities in the market. Benefits associated with the use of fluoroscopy devices such as lesser cost, radiation sensitivity, X-ray recording, and high portability are prominently responsible for the dominance of this segment. Advanced fluoroscopes equipped with radiation reduction features, particularly suited for cardiac interventions further has resulted in augmented market demand. Pairing of fluoroscopy devices with spectral shaping filtering and image intensifiers is touted to further improve image-guided surgeries outcomes and thus increase the adoption of fluoroscopy systems in a larger range of applications.

Based on the type of applications, the global fluoroscopy systems market is segmented as follows:

  • Cardiac Procedures
  • Orthopedic Procedures
  • Vascular and Neurological Procedures
  • Others

mong the considered applications for the purpose of this study, cardiovascular procedures currently occupy the largest revenue share due to significant prevalence of CVDs, thus contributing to higher demand for imaging tools for diagnosis and treatment. High precision of fluoroscopy systems with intense energy projections has additionally widened the applicability of fluoroscopy devices in cardiovascular procedures. Furthermore, growing figures of awareness activities, exhibitions and educational conferences being held by manufacturers is also supporting the growth of this market. Use of C-arms is witnessed to be the highest in orthopedic procedures. Their adoption is the highest in trauma settings, critical care and imaging centers where orthopedic procedures are highest performed. Growing pool of geriatric population and higher incidence of trauma and sports injuries prominently contribute to higher demand for fluoroscopy systems in orthopedics.

Based on the usage areas, the global fluoroscopy systems market is segmented as follows:

  • Hospitals and Specialty Clinics
  • Diagnostic Centers

Hospitals and specialty clinics together accounted for the largest share in the global fluoroscopy systems market. Highest patient admissions in these facilities along with respective readmissions are the clear drivers contributing to the dominance of this segment. Availability of required infrastructure, greater affordability of hospitals to purchase advanced fluoroscopy and C-arm systems and admission of a wide range of patients eligible for use of fluoroscopy-guided procedures further contribute to the growth of this segment. Growing inclination of both private and public hospitals and specialty clinics to improve healthcare efficiency and treatment outcomes also is a key growth driver. Additionally, diagnostic centers segment will witness higher growth rate during the forecast period, majorly attributed by growing inclination of patients and healthcare providers to early disease diagnosis and prompt monitoring for optimum disease management.

Geographically, the global fluoroscopy systems market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

At present, North America accounts for the largest revenue share in the global fluoroscopy systems market. Domicile of a large number of market incumbents in the U.S., better reimbursement policies that favor the patients and evolved healthcare infrastructure are the most prominent factors that support the dominance of North America market on the global front. Rapid research and development activities, and higher preference for minimally invasive procedures are the additional features of this market. Furthermore, consistent growth in prevalence of obesity and incidence of sports injuries, and orthopedic and cardiovascular emergencies significantly attribute to the growth of Asia Pacific market, making the region the fastest progressing regional segment. Entry of major market players in emerging economies of Asia Pacific and respective strong economic growth along with rapid evolution of healthcare infrastructure majorly drive the Asia Pacific fluoroscopy systems market. This market is highly competitive in nature and is witnessing significant growth strategies adopted by market players such as expansion of geographical footprint, collaborative partnerships, and M&A activities.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Fluoroscopy Systems market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Fluoroscopy Systems market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Device
  • Fluoroscopy Devices
  • C-Arms
    •     Mini C-Arms
    •     Full Size C-Arms
  • Accessories

Application
  • Cardiac Procedures
  • Orthopedic Procedures
  • Vascular and Neurological Procedures
  • Others

Usage Area
  • Hospitals and Specialty Clinics
  • Diagnostic Centers

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Fluoroscopy Systems market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Fluoroscopy Systems market?
  • Which is the largest regional market for Fluoroscopy Systems market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Fluoroscopy Systems market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Fluoroscopy Systems market worldwide?
Choose Licence Type
$4325
$6325
$12650
Why Acute
View Other Reports